Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 8, p. 1145, doi. 10.1093/neuonc/noy096
- Publication type:
- Article
Works matching IS 15228517 AND DT 2018 AND VI 20 AND IP 8
Results: 19
1
2
De novo and secondary anaplastic meningiomas: natural history, prognosis, and the TERT promoter.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 8, p. 1009, doi. 10.1093/neuonc/noy101
- By:
- Publication type:
- Article
3
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 8, p. 1011, doi. 10.1093/neuonc/noy097
- By:
- Publication type:
- Article
4
Is it time to reconsider the role of irinotecan for the treatment of high-grade gliomas?
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 8, p. 1144, doi. 10.1093/neuonc/noy092
- By:
- Publication type:
- Article
5
Discordance of IDH mutational status between lesions in an adult patient with multifocal glioma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 8, p. 1142, doi. 10.1093/neuonc/noy080
- By:
- Publication type:
- Article
6
The trials of neuro-oncology clinical research.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 8, p. 1007, doi. 10.1093/neuonc/noy076
- By:
- Publication type:
- Article
7
Erratum.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 8, p. 1146, doi. 10.1093/neuonc/noy069
- Publication type:
- Article
8
Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 8, p. 1101, doi. 10.1093/neuonc/noy035
- By:
- Publication type:
- Article
9
In vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 8, p. 1068, doi. 10.1093/neuonc/noy033
- By:
- Publication type:
- Article
10
Sprouty2 enhances the tumorigenic potential of glioblastoma cells.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 8, p. 1044, doi. 10.1093/neuonc/noy028
- By:
- Publication type:
- Article
11
The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 8, p. 1034, doi. 10.1093/neuonc/noy027
- By:
- Publication type:
- Article
12
Primary glioblastoma cells for precision medicine: a quantitative portrait of genomic (in)stability during the first 30 passages.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 8, p. 1080, doi. 10.1093/neuonc/noy024
- By:
- Publication type:
- Article
13
Identification of novel recurrent ETV6-IgH fusions in primary central nervous system lymphoma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 8, p. 1092, doi. 10.1093/neuonc/noy019
- By:
- Publication type:
- Article
14
Reactive species balance via GTP cyclohydrolase I regulates glioblastoma growth and tumor initiating cell maintenance.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 8, p. 1055, doi. 10.1093/neuonc/noy012
- By:
- Publication type:
- Article
15
Survival impact of postoperative radiotherapy timing in pediatric and adolescent medulloblastoma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 8, p. 1133, doi. 10.1093/neuonc/noy001
- By:
- Publication type:
- Article
16
De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 8, p. 1113, doi. 10.1093/neuonc/nox231
- By:
- Publication type:
- Article
17
Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 8, p. 1122, doi. 10.1093/neuonc/nox228
- By:
- Publication type:
- Article
18
Desmoplastic nodular medulloblastoma in young children: a management dilemma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 8, p. 1026, doi. 10.1093/neuonc/nox222
- By:
- Publication type:
- Article
19
Monoamines in glioblastoma: complex biology with therapeutic potential.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 8, p. 1014, doi. 10.1093/neuonc/nox210
- By:
- Publication type:
- Article